AI assistant
SYNLOGIC, INC. — Director's Dealing 2016
Mar 8, 2016
35028_dirs_2016-03-07_f4506e06-0c4d-4508-bd91-76ea87d1e920.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Mirna Therapeutics, Inc. (MIRN)
CIK: 0001527599
Period of Report: 2015-09-30
Reporting Person: Kim Sinil (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.35 | 2023-12-30 | Common Stock (9062) | Direct | |
| Stock Option (Right to Buy) | $8.10 | 2024-03-10 | Common Stock (14566) | Direct |
Footnotes
F1: This Amendment is being filed solely to correct the balance of shares held by the reporting person with respect to the options restated herein. The aggregate total number of option shares held by the Reporting Person was correctly reported originally.
F2: The option vests with respect to 25% of the shares subject thereto on March 6, 2014, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
F3: The option vests with respect to 25% of the shares subject thereto on March 10, 2015, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.